1. Home
  2. IOVA vs GSM Comparison

IOVA vs GSM Comparison

Compare IOVA & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.97

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.57

Market Cap

964.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
GSM
Founded
2007
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
964.9M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
IOVA
GSM
Price
$3.97
$4.57
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$9.11
$6.00
AVG Volume (30 Days)
16.9M
1.2M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
1.28%
EPS Growth
14.84
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$49.14
$23.36
Revenue Next Year
$51.69
$17.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$2.97
52 Week High
$5.63
$5.74

Technical Indicators

Market Signals
Indicator
IOVA
GSM
Relative Strength Index (RSI) 52.57 41.41
Support Level $1.99 $4.16
Resistance Level $4.34 $4.56
Average True Range (ATR) 0.50 0.28
MACD -0.00 -0.05
Stochastic Oscillator 28.72 21.08

Price Performance

Historical Comparison
IOVA
GSM

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

Share on Social Networks: